IJMS | Free Full-Text | c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
ABL (gene) - Wikipedia
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
BCR-ABL fusion protein
Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL | PLOS ONE
BCR-ABL and Apoptosis: mutated BCR-ABL fusion protein inhibits the... | Download Scientific Diagram
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Targeting BCR-ABL in Chronic Myelogenous Leukemia
BCR/ABL inhibition by an escort/phosphatase fusion protein | PNAS
PF‑114, a novel selective inhibitor of BCR‑ABL tyrosine kinase, is a potent inducer of apoptosis in chronic myelogenous leukemia cells
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
BCR ABL Protein - an overview | ScienceDirect Topics
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Structure of the Abl protein: The 145 kDa Abl protein has two isoforms.... | Download Scientific Diagram
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
NEJM -- Chronic Myeloid Leukemia -- Advances in Biology and New Approaches to Treatment -- Figure 2
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
